key: cord-0921352-zl6qsot6
authors: ZENGİN, Neslihan; GÜVEN, Yusuf Ziya
title: Retinal Microvascular and Perfusional Disruption in Paediatric COVID-19: A Case-Control Optical Coherence Tomography Angiography Study
date: 2021-10-11
journal: Photodiagnosis Photodyn Ther
DOI: 10.1016/j.pdpdt.2021.102577
sha: 325638c807214245d1fbe72a6efefd31e0e52dcb
doc_id: 921352
cord_uid: zl6qsot6

PURPOSE: : To investigate the short-term effect of coronavirus 2019 (COVID-19) on the retinal capillary network and choroid in children. MATERIALS AND METHODS: : This prospective, cross-sectional, case-control study included 19 recovered COVID-19 paediatric patients and 20 healthy children. Macular thickness, choroidal thickness, vessel density (VD), perfusion density (PD), and foveal avascular zone (FAZ) values were obtained. Central vessel and perfusion densities were measured at the central 6-mm area, and the values were compared among three subgroups according to location. RESULTS: : The mean ages of patients and controls were 12.42 ± 3.3 years and 13.35 ± 1.2 years, respectively. Significant differences were observed between the two groups in terms of inner, outer, and full VD, as well as inner and full PD. No significant differences in centre VD and PD were observed between groups. Although it was not evident in analysis of choroidal values, inflammatory sites were thickened. FAZ area significantly differed between groups (p < 0.05). CONCLUSIONS: : Retinal microvascularity was impaired in the acute phase of disease in recovered COVID-19 patients aged 10–15 years. However, the microvascularity impairment was subclinical. The choroid was thickened because of inflammation during the acute phase of disease. Paediatric COVID-19 patients should undergo follow up via optical coherence tomography angiography to detect subclinical retinal changes. (Clinically asymptomatic retinal changes) Long-term follow-up studies are needed to validate these findings.

Coronavirus 2019 (COVID-19) disease is a global public health issue caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan, China in December 2019, and has been declared a pandemic by the World Health Organization. [1] SARS-CoV-2 is an enveloped, single-stranded RNA virus. [1] At the beginning of the pandemic, respiratory disease (e.g., pneumonia) was emphasised; however, COVID-19 may cause various clinical symptoms, including multiple organ failure. The multi-organ involvement in COVID-19 may be explained by the viral proliferation cycle. Angiotensinconverting enzyme-2 (ACE-2) receptors provide a route of cellular entry for SARS-CoV-2. [2, 3] Because ACE-2 receptors are present on multiple organs (e.g., eyes, lungs, liver, heart, and kidneys), COVID-19 may affect multiple organs. [4, 5] COVID-19 can also cause coagulopathies. Endothelial dysfunction initiates coagulopathy by causing an increase in thrombin production and fibrinolysis. [6] COVID-19 can involve any organ that is within the reach of the vascular system.

Previous studies have identified ophthalmological involvement in COVID-19 patients.

In particular, cases of conjunctivitis have been reported in children and adults with COVID-19. [7, 8] Although some studies have reported posterior segment involvement in COVID-19 patients, such involvement mostly occurs in adults. [9, 10] Here, we used optical coherence tomography angiography (OCTA) to examine posterior segment involvement in children with COVID-19. OCTA is a new generation of non-invasive devices, which displays blood flow with high resolution in the retina and choroid, thereby providing information regarding ischemia.

Although most previous studies have exclusively included adults, some reviews and clinical follow-up studies have suggested that posterior segment involvement has a better prognosis in children than in adults. [11, 12] Thus, we aimed to investigate chorioretinal changes that occur in the acute phase of COVID-19 in children. OCTA images were obtained using an RS-3000 Advance device (NIDEK Co., Ltd., Tokyo, Japan). This device features a wavelength of 880 nm and an A-scan speed of 53,000 per second. The retinal capillary plexus was analysed using AngioScan software (NIDEK Co., Ltd.). Using the fovea as the internal fixation source, macular cube areas of 3 × 3 mm and 6 × 6 mm were created, each consisting of 256 B-scans. The macula was then divided into inner, outer, central, and full subgroups in a 6 × 6-mm area, in accordance with the method used in the Early Treatment Diabetic Retinopathy Study. Vessel density (VD) and perfusion density (PD) measurements were automatically obtained for all subgroups. In addition, the fovea avascular zone (FAZ) area, perimeter, and circularity values were recorded. Four additional choroidal measurements were acquired to determine central foveal thickness, including 600 and 1200 microns (µ) from the centre, nasal, and temporal regions. All values were saved in Microsoft Excel format.

SPSS software (version 22.0; IBM Corp., Armonk, NY, USA) was used for statistical analysis. The normality of all data was evaluated. Non-normally distributed data were analysed using the non-parametric Mann-Whitney U test. The results were calculated with 95% confidence intervals, and p-values < 0.05 were considered statistically significant.

This study included 19 recovered COVID-19 patients (girls: 7, 36%; boys: 12, 64%) and 20 controls (girls: 10; boys: 10). The mean ages of the patients and controls were 12.42 ± 3.3 years and 13.35 ± 1.2 years, respectively (Table 1) ; the corresponding mean visual acuities were 1.0 and 0.0 logMAR. Significant differences were observed between patients and controls in terms of C-reactive protein level, D-dimer level, and sedimentation rate (p = 0.019, p = 0.001, and p = 0.001, respectively) ( Table 1) . Although the choroidal thickness values did not significantly differ between groups, minimal thickening was noted in patients, compared with controls ( Figure 1 ). For example, choroidal thicknesses measured from the central foveal area in patients and controls were 334.9 ± 33.7 µ and 311.2 ± 17.5 µ, respectively. Although the choroidal thickness values from the nasal and temporal quadrants were not significantly different between patients and controls, the patients exhibited choroidal thickening ( Table 2 ).

The central foveal thickness and mean macular thickness in patients were 248.0 ± 16.9 µ and 270.8 ± 66.5 µ, respectively; in controls, they were 267.1 ± 19.8 µ and 305.5 ± 9.2 µ, respectively. These values significantly differed between patients and controls (p = 0.003 and p = 0.001, respectively). While centre VD values did not significantly differ between groups, they were lower in patients than in controls (3.8 ± 0.9 and 4.1 ± 1.1, respectively). The inner, outer, and full VD values were significantly lower in patients than in controls (Table 3) .

Similar results were observed regarding PD values. Inner and full PD values were significantly lower in patients than in controls (Table 3) . Centre and outer PD values did not significantly differ between patients and controls (p = 0.496 and p = 0.627, respectively).

Additionally, a significant expansion of FAZ area was observed among patients, compared with controls (p = 0.001; Figure 2 ). The FAZ areas in patients and controls were 1.65 ± 6.1 and 0.4 ± 0.1 mm 2 , respectively. Significant differences were also observed between groups in terms of perimeter and circularity values (p = 0.001 for both) ( Table 3 ).

COVID-19 causes respiratory symptoms, as well as coagulopathy, endotheliopathy, and vasculitis. [13, 14] Multiple organ failures may occur in COVID-19 patients because of widespread ACE-2 receptor distribution in various end organs, as well as extensive coagulopathy. [15, 16] Anterior and posterior segments reportedly exhibit involvement in COVID-19 patients. In this study, we used capillary OCTA to investigate the retinal effects of COVID-19 in children. Previous studies regarding the retinal effects of COVID-19 have exclusively focused on adults; to our knowledge, this is the first such study to include children.

Previous studies have reported that SARS-CoV-2 infection triggers substantial inflammation. [5, 17] The American Physiological Society reported that COVID-19 is a cause of -thromboinflammation,‖ which is consistent with the physiopathology of COVID-19.

Previous clinical studies and case reports have indicated that children are less likely than adults to become infected with SARS-CoV-2; children also exhibit a milder disease course. [18, 19] These differences may be explained by a few observations. The number of ACE-2 receptors, used by the SARS-CoV-2 virus to enter the cell [2] , decreases with age; this results in failed angiotensin-2 (ANJ-2) catabolism. [20, 21] ANJ-2 has vasoconstrictor, fibrotic, and pro-inflammatory effects. SARS-CoV-2 may also downregulate ACE-2 receptors upon entry into the cell. [22] Therefore, ANJ-2 levels may increase again, leading to undesirable effects. Because children have higher levels of ACE-2 receptors, the impact of COVID-19 may be limited.

The inflammatory component of the aforementioned thromboinflammation is related to ACE-2. Additionally, SARS-CoV-2 may also cause endotheliitis, vasculitis, and a hypercoagulable state. Iba et al. [13] reported that the coagulation cascade is triggered by endotheliopathy caused by direct endothelial infection and the indirect effects of inflammation. In the same study, it was found that D-dimer and fibrinogen levels increased in There are many potential reasons for such changes. Endotheliitis, caused by the pro-inflammatory state during the acute phase of disease, may have triggered these changes. An Cotton wool spots represent ischemic areas. In the same study, vessels around the optic nerve head with diameters of 0.5 and 1 disc were automatically segmented by the software. The software selected four main vessels to obtain the mean artery and mean vein diameters, then automatically calculated these diameters. Significantly increased mean artery and mean vein diameters were found in COVID-19 patients. [10] Vein length was also associated with disease severity. A molecular study of arterial responses under short-term hypoxic conditions demonstrated arterial dilatation mediated by various receptors. [28] In the present study, although patients were examined during the acute phase of disease, the observed changes in PD may have been caused by short-term hypoxia. Similarly, studies that investigated the relationship between retinal veins and oxygen saturation reported a wider diameter of retinal veins under lower arterial oxygen saturation levels. [29] These findings may explain the negative impact of COVID-19-associated ischemia on PD. In our study, we also found increased FAZ area among COVID-19 patients; this was presumably related to temporary ischemia and microthrombi during the acute phase of disease.

In a previously reported case, unilateral panuveitis and optic neuritis occurred prior to pulmonary symptoms. The authors of that report presumed that this progression was caused by inflammation or ischemia; the inflammation may have been caused by direct viral infiltration into ocular or choroidal tissue. [30] In our study, we also investigated the choroid to evaluate its role in the spread of inflammation. Although the difference was not statistically significant, we found increased choroidal thickness in all five measurements performed at intervals between 600-1200 µ from the central, nasal, and temporal regions. This implies choroidal inflammation during the acute phase of COVID-19, which may damage the outer retinal layer vasculature. Our findings of reduced central and mean macular thicknesses may represent temporary changes caused by early choroidal inflammation.

As previously mentioned, several factors may explain why these observed changes do not cause clinical symptoms, especially in children. First, higher ACE-2 levels in children enable metabolization of ANJ-2, preventing the clinical symptoms of its anti-fibrotic, antiinflammatory, and vasodilator effects. Second, the presence of a healthier endothelial structure in children may protect against damage. Although these factors lead to a better prognosis among children, our OCTA findings demonstrate subclinical changes, which suggest the need for ophthalmological follow-up (e.g., detailed posterior segment examinations) among children with COVID-19.

There were some limitations in our study. First, this study included a small sample size. However, it is more difficult to obtain high-signal-strength OCTA images in children than in adults. Second, we only evaluated patients in the acute phase of the disease; we did not investigate long-term changes, which should be the focus of future studies.

In conclusion, COVID-19 patients may exhibit ophthalmological involvement, which merits further investigation. Ophthalmological involvement with COVID-19 affects both the anterior and posterior segments. Therefore, posterior segment examinations should also be performed. Importantly, children can also exhibit subclinical ophthalmological involvement; they should undergo follow-up eye examinations. The above statement is here to inform reviewers-who may not be native speakers of English-that the English in this document has been professionally checked. If the link to the certificate above is deleted and copied into a letter then the reviewers will not see it.

We STRONGLY recommend that no changes are made. Textcheck should be the last step before final formatting. Typically, authors' changes result in errors in the English, not improvements.

If any text has been misunderstood then please REWRITE the sentence(s) that you need to change, using this file, SAVE, and upload a clean (unmarked) final version of the document 

Epidemiology, Pathogenesis, and Control of COVID-19. Viruses

The molecular virology of coronaviruses

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2

COVID 19 gate way to multiple organ failure syndromes

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases

A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis

Reduced retinal vessel density in COVID-19 patients and elevated D-dimer levels during the acute phase of the infection

Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine

The coagulopathy, endotheliopathy, and vasculitis of COVID-19

COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response

SARS-CoV-2 and coagulation disorders in different organs

Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation

Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets

Coronavirus Disease 2019 in Children -United States

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Pathophysiology of COVID-19: Why Children Fare Better than Adults?

Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections

Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications

Ocular pathology and occasionally detectable intraocular SARS-CoV-2 RNA in five fatal COVID-19 cases

Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients

Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: a case-control study

Retinal microvascular abnormalities in patients after COVID-19 depending on disease severity

Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography

Short Periods of Hypoxia Upregulate Sphingosine Kinase 1 and Increase Vasodilation of Arteries to Sphingosine 1-Phosphate (S1P) via S1P(3)

Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters. The Rotterdam Study

Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19)